Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2019
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Tris(trimethylsilyl) phosphate
EC Number:
234-028-1
EC Name:
Tris(trimethylsilyl) phosphate
Cas Number:
10497-05-9
Molecular formula:
C9H27O4PSi3
IUPAC Name:
tritrimethylsilyl phosphate
Specific details on test material used for the study:
Test Item Tris(trimethylsilyl) Phosphate
Lot Number DV1105A19028
CAS No 10497-05-9
EINECS-No 234-028-1
Molecular Formula C9H27O4PSi3
Molecular Weight 314.54
Purity 99.60%
Appearance Colorless, clear liquid
Composition Single component
Homogeneity Not stated
Storage Room temperature (20 ± 5 °C)
Test Item Handling and Storage According to SOPA-00147-BIO, Test and Reference Items

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
Age at First Dose 8-9 weeks; female animals were non-pregnant and nulliparous
Animal Health Health condition of animals was examined by a veterinarian before initiation of the study.
Acclimation The animals were acclimated under the conditions identical to the conditions during the experiment 5 days prior to the start of treatment. The acclimation was according to the standard operation procedure.
Housing Condition The animals were housed in plastic cages suspended on stainless steel racks, 3 animals per cage in a room equipped with central air-conditioning. The average room temperature was maintained within the range of 22 ± 3°C, relative humidity within 50-60 %. The light regimen was set to a 12-hour light /12-hour dark cycle. The sanitation was performed according to the standard operation procedures.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Doses:
The starting dose could be selected from the fixed dose levels of 5, 50, 300, and 2000 mg/kg body weight.
No. of animals per sex per dose:
One group of 3 females was dosed in a first step. The test item in limit dose caused mortality of two animals within the first day after administration and the third animal died on the second day. In a second step, 3 females were treated at dose of 300 mg/kg body weight. Test item-related mortality was not observed for 48 hours and therefore, in a third step, another 3 females were treated at the same dose cap
Details on study design:
The test item Tris(trimethylsilyl) Phosphate administered to 3 females Wistar rats at a limit dose of 2000 mg/kg caused lethargy, dyspnea in all animals immediately after administration and piloerection after 4 hours in animal No 3. Animals No 1 and 2 died within the first day after test item administration. Animal No 3 manifested lethargy, dyspnea and piloerection until the death the second day after administration. During necropsy, no macroscopic findings were observed.

Results and discussion

Effect levels
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 300 - < 2 000 mg/kg bw
Mortality:
Mortality of 3/3 females at limit dose of 2000 mg/kg body weight was observed.
All (6/6 females) animals survived the dose of 300 mg/kg body weight.
Other findings:
All animals were necropsied. During necropsy, no macroscopic findings were observed.

Any other information on results incl. tables

 Clinical observation

Sex

Dose

ID

Administration

 Result

Clinical Observation

2000 mg/kg

1

death

- lethargy and dyspnea immediately, persisted for 4 hours

- piloerection after 4 hours after administration

- death the first day after administration of the test item

2

death

- lethargy and dyspnea immediately, persisted for 4 hours

- piloerection after 4 hours after administration

- death the first day after administration of the test item

3

death

- lethargy and dyspnea immediately persisted for 4 hours

- piloerection after 4 hours after administration;

- first day lethargy, piloerection and dyspnea occurred

- second day lethargy, piloerection and dyspnea occurred until death of animal (on second day)

Sex

Dose

ID

Administration

Result

Clinical Observation

300

mg/kg

4

alive

no signs of intoxication, change of health, nor any other adverse reactions during 24 hours and 14-days observation period

5

alive

no signs of intoxication, change of health, nor any other adverse reactions during 24 hours and 14-days observation period

6

alive

- salivation, lethargy and piloerection was observed immediately

- lethargy persisted for ½ an hour

- piloerection was observed until 2ndhour after administration

7

alive

- lethargy was observed immediately and persisted for ½ an hour

- sleep was observed ½ an hour after administration

8

alive

- lethargy was observed immediately

9

alive

- lethargy was observed immediately

Body Weight

Sex

Dose

ID

Body Weight (g)

Body Weight Difference (g)

Initial

Week 1

Week 2

Week 1 - Initial

Week 2 - Initial

Week 2 - Week 1

2000 mg/kg

1

213

-

-

-

-

-

2

201

-

-

-

-

-

3

206

-

-

-

-

-

 

 

 

 

 

 

300 mg/kg

4

216

246

252

30

36

6

5

216

246

261

30

45

15

6

226

245

251

19

25

6

7

216

233

238

17

22

5

8

224

245

258

21

34

13

9

213

236

238

23

25

2

Necropsy Results     

Sex

Dose

ID

Result

2000 mg/kg

1

autolytic changes

2

autolytic changes

3

no findings

300 mg/kg

4

no findings

5

no findings

6

no findings

7

no findings

8

no findings

9

no findings

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
The LD50 of the test item Tris(trimethylsilyl) Phosphate is greater than 300 mg/kg and lower than 2000 mg/kg body weight after single oral administration to Wistar rats.
Based on Annex 2d Test Procedure with a Starting Dose of 2000 mg/kg body weight of OECD Guideline 423 it can be concluded that the test item Tris(trimethylsilyl) Phosphate is classified in GHS Category 4 with a LD50 cut off value 500 mg/kg body weight, after single oral administration to Wistar rats.